During her tenure at CTI, Kelly has been a critical resource for the Business Development Team, R&D, Quality and Operations. Kelly has successfully guided CTI through numerous customer audits, ISO and FDA inspections all without interruption to our regular business. Additionally, Kelly has played and will continue to play, a significant role in bringing the ChemDx project to market.
Elevating Kelly to a new level of responsibility will ensure that both the Regulatory and Quality departments continue to evolve along with the needs of the company.